文献速递肺栓塞与肺血管病

白细胞计数作为急性肺栓塞院内预后指标:注册研究与遗传学分析

Leukocyte Count as an In-Hospital Prognostic Indicator in Acute Pulmonary Embolism: Evidence From a Registry Study and Genetic Analyses.
PubMed 文献 · Respirology · 2025-12-10

基于全国多中心前瞻性注册研究,开发并验证纳入白细胞计数与sPESI的院内死亡预测模型,并在另一队列中验证。白细胞升高组院内全因死亡率更高,白细胞计数联合sPESI可提升预后准确性,孟德尔随机化分析提示白细胞升高与死亡风险增加相关。

要点

  • 入院白细胞计数>10×10⁹/L的肺栓塞患者院内全因死亡率更高。
  • 白细胞计数联合sPESI可小幅提升院内死亡预测的AUC。
  • 孟德尔随机化提示白细胞升高与死亡风险增加相关。

核心结论

  • 入院白细胞计数可增强sPESI对急性肺栓塞患者院内全因死亡的预测准确性。
  • 白细胞计数可作为识别急性肺栓塞高死亡风险患者的潜在生物标志物。

研究设计与样本

  • 研究基于全国多中心前瞻性注册研究,纳入急性肺栓塞患者数据,开发并验证纳入白细胞计数与sPESI的院内死亡预测模型。
  • 采用孟德尔随机化(MR)分析评估白细胞计数与死亡之间的关系。
  • 开发队列共纳入7312例肺栓塞患者,验证队列共纳入7660例肺栓塞患者。

主要发现

  • 按入院白细胞计数分为三组:<4×10⁹/L组301例(4.1%)、(4-10)×10⁹/L组5074例(69.4%)、>10×10⁹/L组1937例(26.5%)。
  • 白细胞增多组贫血、血小板减少、低氧血症、心脏和肾脏损伤及血流动力学不稳定的患病率更高。
  • 三组院内全因死亡率分别为3.0%、2.3%和6.4%(p<0.001)。
  • sPESI的AUC为0.719(95%CI 0.681-0.756,p<0.001),联合白细胞计数分组后升至0.738(95%CI 0.701-0.775,p<0.001)。
  • MR分析显示白细胞计数升高增加死亡风险(OR=1.11,95%CI 1.00-1.24,p=0.047)。

临床怎么用

  • 对急性肺栓塞患者,入院时检测白细胞计数有助于识别院内死亡高风险人群。
  • 可将白细胞计数与sPESI联合用于院内死亡风险评估,以提升预测准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: As a well-established inflammatory biomarker, leukocyte count is associated with higher mortality in acute pulmonary embolism (PE). We aimed to confirm the prognostic utility of leukocyte count and its integration with simplified Pulmonary Embolism Severity Index (sPESI) for predicting all-cause hospital mortality in acute PE. METHODS: Data derived from a national, multicentre and prospective registry including patients with acute PE were analysed to develop and validate an in-hospital mortality prediction model incorporating leukocyte count and sPESI. Mendelian Randomisation (MR) was performed to assess the relationship between leukocyte count and mortality. RESULTS: A total of 7312 PE patients were stratified into three groups based on admission leukocyte count: < 4 × 109/L (n = 301, 4.1%), (4-10) × 109/L (n = 5074, 69.4%) and > 10 × 109/L (n = 1937, 26.5%). Patients with leukocytosis exhibited a higher prevalence of anaemia, thrombocytopenia, hypoxemia, cardiac and renal injury, as well as haemodynamic instability. The in-hospital all-cause mortality was 3.0%, 2.3% and 6.4% (p < 0.001) across the three groups, respectively. The area under the curve (AUC) of sPESI was 0.719 (95% CI 0.681-0.756, p < 0.001), increasing to 0.738 (95% CI 0.701-0.775, p < 0.001) when combined with leukocyte count groups. The prognostic value of leukocyte count and its combination with sPESI was validated in a cohort with 7660 PE patients. MR analysis demonstrated that elevated leukocyte counts increased mortality risk (OR = 1.11, 95% CI 1.00-1.24, p = 0.047). CONCLUSION: Admission leukocyte count enhances the prognostic accuracy of sPESI for in-hospital all-cause mortality in PE. Leukocyte count could serve as a potential biomarker for identifying PE patients at increased mortality risk.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Zhang, Li, Chen, et al. Leukocyte Count as an In-Hospital Prognostic Indicator in Acute Pulmonary Embolism: Evidence From a Registry Study and Genetic Analyses. Respirology. 2025. PMID: 41371724. doi:10.1002/resp.70171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。